Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
Tyler Kaplan, MD
Advertisement
Assistant Professor, Department of Neurological Sciences, RUSH Medical College, Chicago, IL
Articles by Tyler Kaplan, MD
Advertisement
Latest Updated Articles
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?Published: March 2nd 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 2 OPAL Study to Test Muscle-Targeting Therapy Apitegromab in Infants With SMA
2
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology
3
Interim ROSSINI Data Highlight Foslevodopa/Foscarbidopa’s Impact in Advanced Parkinson Disease
4
Inside the Phase 3 MASCOT Trial: Lundbeck’s Push for the First Disease-Modifying MSA Therapy
5
